TheEdgeResearch
Home / Stocks / MRMD.CN

MariMed Inc. (MRMD.CN)

CNQ Healthcare Drug Manufacturers - Specialty & Generic
$0.10 ▲ +0.00%
Market Cap
$37.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.32
52-Wk Range
0.08-0.48
CEO
Jon R. Levine
Country
US
Currency
CAD

MariMed Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Norwood, MA, US. The stock last traded at $0.10, up 0.00% on the session, giving a market capitalisation of $37.9M. Its beta of 1.32 implies it has historically moved more than the broad market.

Company profile
Exchange
Canadian Securities Exchange
Employees
866
IPO date
2022-07-14
Headquarters
Norwood, MA, US
About MariMed Inc.

MariMed Inc. is a key player in the cannabis industry, involved in the cultivation, production, and distribution of both medicinal and adult-use cannabis products across the United States and internationally. The company's diverse brand portfolio includes Nature's Heritage for cannabis genetics, flowers, and concentrates, while Kalm Fusion offers cannabis-infused chewable tablets and powdered drink mixes. Its edibles segment features natural fruit chews under the Betty's Eddies brand and a variety of baked goods like brownies and cookies from Bubby's Baked. Additionally, MariMed develops cannabidiol (CBD) formulations under the Florance brand. The company further expands its operations by licensing its proprietary brands and product formulations, and by leasing cannabis-specific facilities. MariMed Inc. was founded in 2011 and maintains its headquarters in Norwood, Massachusetts.

Comparable companies

MariMed Inc. is most often compared with the following Healthcare names:

BLO.CNCBST.NECXXI.CNDB.VEPIC.CNIAN.CNINNO.CNLEEF.CNPLTH.CNVEXT.CN
More research on MRMD.CN
MRMD.CN technical analysis MRMD.CN TheEdge Score Compare against peers
Open full interactive analysis & DCF →